Pristimerin Inhibits Osteoclast Differentiation and Bone Resorption in vitro and Prevents Ovariectomy-Induced Bone Loss in vivo

INTRODUCTION: Osteoporosis is a metabolic bone disease characterized by reduced bone quantity and microstructure, typically owing to increased osteoclastogenesis and/or enhanced osteoclastic bone resorption, resulting in uncontrolled bone loss, which primarily affects postmenopausal women. In consid...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Drug Des Devel Ther
Main Authors: Sun, Peng, Yang, Qichang, Wang, Yanben, Peng, Jiaxuan, Zhao, Kangxian, Jia, Yewei, Zhang, Tan, Lu, Xuanyuan, Han, Weiqi, Qian, Yu
Formato: Artigo
Idioma:Inglês
Publicado: Dove 2020
Assuntos:
Original Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7553770/
https://ncbi.nlm.nih.gov/pubmed/33116407
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S275128
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares